Attenuated diphtheria toxin mediates siRNA delivery

Area of Science:

• Biotechnology
• Molecular Biology
• Cancer Research

Background:

• Toxins naturally deliver cargo into cells via endocytosis and endolysosomal escape.
• Targeted delivery of therapeutic agents like siRNA is crucial for cancer treatment.

Purpose of the Study:

• To utilize an attenuated diphtheria toxin as a novel vehicle for siRNA delivery.
• To achieve gene downregulation and observe functional outcomes in patient-derived glioblastoma cells.

Main Methods:

• Conjugating an attenuated diphtheria toxin to small interfering RNA (siRNA).
• Delivering siRNA targeting integrin-β1 (ITGB1) and eukaryotic translation initiation factor 3 subunit b (eIF-3b) to glioblastoma cells.
• Assessing mRNA downregulation and phenotypic changes using a 3D hydrogel invasion model and cell death assays.

Main Results:

• Successful delivery of siRNA targeting ITGB1 and eIF-3b using the diphtheria toxin conjugate.
• Demonstrated significant inhibition of glioblastoma cell invasion upon ITGB1 knockdown.
• Observed significant glioblastoma cell death following eIF-3b knockdown.

Conclusions:

• This study presents the first use of diphtheria toxin for siRNA delivery.
• Toxin-based siRNA delivery effectively induces genotypic and phenotypic changes in cancer cells.
• This strategy holds potential for developing new cancer therapies.